Skip to main content

Tweets

A New ACR Dr. Jack Cush highlights a few notable changes to the ACR meeting format this year, and offers pointers on the best way to stay informed and abreast of reporting from the #ACR24 Convergence meeting in Washington, DC. https://t.co/YmI6s1TanV https://t.co/hsByGEBtnz
Dr. John Cush @RheumNow ( View Tweet )
1 year 2 months ago
A#2648 PET for GCA Delayed imaging at 180 min improve dx performance for pts on GCs Optimal PET w/in 3 days of GC, most patients unable to do w/in that window Delay has sensitivity 92% even on prednisone - may be good tool for pts unable to get early PET/CT #ACR24 @RheumNow https://t.co/kxpNfRqkGN
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
Study by Maria Dall'Era et al. compared voclosporin-based triple immunosuppressive therapy with high-dose GC in active lupus nephritis. - Fewer adverse events in the voclosporin group, despite a higher incidence of specific issues like decreased GFR and hypertension. - 25%… https://t.co/ToRu2rdErC https://t.co/uUXzNNuLDb
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 year 2 months ago
@YooJinKimYJK @andreafava et al: 20% of pts in their #lupus cohort had recurrent pericarditis. Majority had 1 recurrence (51%) Independent predictors of recurrence: Younger age Prednisone tx Active dse Time from initial episode 🔅regular ffup is 🔑 @RheumNow #ACR24 abs2372 https://t.co/UELwE31X0u
1 year 2 months ago
➡️More DMARD-exposed pts w late-onset RA reduce long-term GC use than DMARD-unexposed ➡️Persistent GC use is common ➡️In DMARD-exposed, GC use may be related to limited access to high-cost drugs ➡️In DMARD-unexposed, comorbidity burden may limit DMARD use Ab2606 #ACR24 @RheumNow

Mrinalini Dey @DrMiniDey ( View Tweet )

1 year 2 months ago
How do you manage DMARDs when giving the recombinant #zoster #vaccine (#RZV)? ➡️75 pts with ARDs 💉2-week #MTX discontinuation after each dose of RZV ⏩Significant boost in immune response without difference in flare rates Ab2612 #ACR24 @RheumNow https://t.co/o4iqj3e1Be
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 2 months ago
A#2649 Relapsing Polychondritis Latent Class Analysis to define clinical phenotypes of heterogeneous dx Type 1- ear, nose, subglottic stenosis 2- tracheo/bronchomalacia 3- absence tracheomalacia Decision tree to classify pts in subgroups #ACR24 @RheumNow https://t.co/xpZedPVl7f
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
Loiseau et al. 4700 pSS, 47000 comparators. pSS associated with increased risk of every CV/VTE outcome. Did not have that in my priors! @RheumNow #ACR24 Abstr#2631 https://t.co/QKemUhbcG8 https://t.co/twpjdS2L63
Richard Conway @RichardPAConway ( View Tweet )
1 year 2 months ago
A#2650 MRI can show extent of vessel wall inflamm to guide severity of GCA Brain & orbital MRI performed Assessed 7 arteries bilaterally -> CAMRIS-GCA MRI score (0-10) 33 GCA (17 ocular), 41 not GCA CAMRIS-GCA ass w/ ocular GCA, higher severity. Improved w Rx @RheumNow #ACR24 https://t.co/19XCuZJXqF
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
Among axSpA patients enrolled in the BE MOBILE 1&2, those who received Bimekizumab achieved ASAS40 response earlier vs PBO Improvements in spinal pain and physical function were significantly reported as early as wk 1 in those who received BKZ vs PBO @RheumNow #ACR24 abs2363 https://t.co/JmcQdURTY4
1 year 2 months ago
A re-evaluation of lupus arthritis. Old dogma is RA is erosive and SLE non-erosive. With better imaging, lupus arthritis can be erosive. Vivianne Malstrom. @RheumNow #ACR24 https://t.co/JEqVPLGNfu
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 year 2 months ago
Did you know? #Lupus arthritis have clinical and US classifications. On MRI, findings will show: - periarticular hyperplastic tissue - capsular swelling - edematous tenosynovitis @RheumNow #ACR24 @rheumarhyme @theactiverheum https://t.co/EoKh2Q3V9Z
1 year 2 months ago
×